Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 1;22(4):215-220.
doi: 10.1097/ACI.0000000000000835.

Global patterns of drug allergy-induced fatalities: a wake-up call to prevent avoidable deaths

Luciana K Tanno  1   2   3 , Amélie Gauthier  1   4 , Salome Allichon  1 , Pascal Demoly  1   2   3
Affiliations

Global patterns of drug allergy-induced fatalities: a wake-up call to prevent avoidable deaths

Luciana K Tanno et al. Curr Opin Allergy Clin Immunol. .

Abstract

Purpose of review: To identify patterns and key issues though a systematic review in order to support prevention strategies and reduce avoidable deaths related to drug-induced anaphylaxis (DAF).

Recent findings: DAF rate has been estimated by 0.13-0.53/106 population/year. General global trends of DAF are increasing over time, mostly occurring at healthcare settings (62%) with a similar gender distribution and an average age of 53 years. Antibiotics, anaesthetics, radio-contrast media and NSAIDs were the most frequently implicated agents. Main comorbidities were personal history of drug allergy, cardiovascular diseases and asthma. Main manifestations were cardiovascular and respiratory commitments. Use of adrenaline is mentioned in only 29% of the articles.

Summary: DAF is increasing worldwide and most cases are iatrogenic. This first systematic review of DAF identified key gaps and served as a wake-up call to prevent avoidable deaths. Phenotype at risk for DAF was represented by patients aged more than 54 years, with personal history of drug allergy/hypersensitivity with no or incomplete allergological work-up, cardiovascular disease and/or asthma with need of hospitalization and/or frequent healthcare assistance. Additional risk for those who need frequent use of intravenous antibiotics and/or undergoing surgery or image investigation with radiocontrast media.

PubMed Disclaimer

References

    1. Wheatley LM, Plaut M, Schwaninger JM, et al. Report from the National Institute of Allergy and Infectious Diseases workshop on drug allergy. J Allergy Clin Immunol 2015; 136:262–271.
    1. Pouessel G, Lejeune S, Deschildre A, et al. Mortalité par anaphylaxie en France métropolitaine: analyse des données nationales de 1979 à 2011. Revue Francaise d’Allergologie 2017; 57:525–532.
    1. Kleinrock M, Muñoz E. Global medicine spending and usage trends: outlook to 2024. IQVIA Institute for Human Data Science. 2020. pp. 1–26.
    1. Pumphrey RSH, Roberts ISD. Postmortem findings after fatal anaphylactic reactions. J Clin Pathol 2000; 53:273.
    1. Jerschow EMDM, Lin RYMDM, Scaperotti MMBS, et al. Fatal anaphylaxis in the United States, 1999–2010: Temporal patterns and demographic associations. J Allergy Clin Immunol 2014; 134:1318–1328.

Publication types